Super Purchasing for COVID-19 Antigen Lateral Flow Assay - Carbapenem-resistant KPC Detection K-Set (Lateral Flow Assay) – Genobio


Product Detail

Product Tags

Related Video

Feedback (2)

We often persist with the theory "Quality To start with, Prestige Supreme". We are fully committed to delivering our clientele with competitively priced good quality items, prompt delivery and experienced support for Vacuum Blood Collection Tube (Clot Activator), invasive candidiasis, Serum Amyloid A test, We are able to customize the solutions according to your needs and we can easily pack it for you when you purchase.
Super Purchasing for COVID-19 Antigen Lateral Flow Assay - Carbapenem-resistant KPC Detection K-Set (Lateral Flow Assay) – Genobio Detail:

Product Introduction

The Carbapenem-resistant KPC Detection K-Set (Lateral Flow Assay) is an immunochromatographic test system intended for the qualitative detection of KPC-type carbapenemase in bacterial colonies. The assay is a prescription-use laboratory assay which can aid in the diagnosis of KPC-type carbapenem resistant strains.

Carbapenem-resistant NDM Detection K-Set (Lateral Flow Assay) 1

Characteristics

Name

Carbapenem-resistant KPC Detection K-Set (Lateral Flow Assay)

Method

Lateral Flow Assay

Sample type

Bacterial colonies

Specification

25 tests/kit

Detection time

10-15 min

Detection objects

Carbapenem-resistant Enterobacteriaceae (CRE)

Detection type

KPC

Stability

The K-Set is stable for 2 years at 2°C-30°C

Carbapenem-resistant K.N.I.

Advantage

  • Rapid
    Obtain result within 15 min, 3 days earlier than traditional detection methods
  • Simple
    Ordinary laboratory staff can operate without training
  • Accurate
    High sensitivity and specificity
    Low detection limit: 0.50 ng/mL
    Able to detect most of the common subtypes of KPC
  • Intuitive result
    Visual reading result, easy and clear
  • Economic
    Product can be transported and stored at room temperature, reducing costs

The importance of CRE test

Carbapenem antibiotics are one of the most effective drugs for the clinical control of pathogenic infections. Carbapenemase-producing organisms (CPO) and carbapenem-resistant Enterobacter (CRE) have become a global public health issue due to their broad-spectrum drug resistance, and treatment options for patients are very limited. People worldwide should pay great attention on preventing the spread of CRE, which, if not limited, will seriously affect the clinical treatment of many diseases, making it increasingly difficult to cure and control diseases.

Usually, healthcare providers can help prevent the spread of CRE by

  • Monitoring CRE infections carefully in healthcare facilities
  • Isolate patients with CRE
  • Removing medical devices that are inside the body, and reducing invasive treatment methods
  • Be careful when prescribing antibiotics (especially carbapenems), only if it is really needed
  • Using clean (sterile) techniques to minimize the spread of infection

……
All these indicate the importance of early detection of CRE. To develop rapid diagnostic products is of great significance for the early typing of drug-resistant strains, the guidance of medication, and the improvement of human’s medical and health standards.

KPC-type carbapenemase

Carbapenemase refers to a type of β-lactamase that can at least significantly hydrolyze imipenem or meropenem, including A, B, D three types of enzymes classified by Ambler molecular structure. Class A, such as KPC-type carbapenemase, have been detected primarily in Enterobacteriaceae bacteria. Klebsiella pneumoniae carbapenemase, briefed as KPC, has become one of the most important contemporary pathogens, while the optimal treatment remains undefined. Infections due to KPCs are associated with high therapeutic failure and mortality rates of at least 50%.

Operation

  • Add 5 drops of sample treatment solution
  • Dip bacterial colonies with a disposable inoculation loop
  • Insert the loop into the tube
  • Add 50 μL to the S well, wait for 10-15 minutes
  • Read the result

Carbapenem-resistant KPC Detection K-Set (Lateral Flow Assay) 2

Order Information

Model

Description

Product code

CPK-01

25 tests/kit

CPK-01


Product detail pictures:

Super Purchasing for COVID-19 Antigen Lateral Flow Assay - Carbapenem-resistant KPC Detection K-Set (Lateral Flow Assay) – Genobio detail pictures


Related Product Guide:

Adhering to your principle of "quality, assistance, performance and growth", we have now gained trusts and praises from domestic and international customer for Super Purchasing for COVID-19 Antigen Lateral Flow Assay - Carbapenem-resistant KPC Detection K-Set (Lateral Flow Assay) – Genobio , The product will supply to all over the world, such as: Morocco, Gambia, Zimbabwe, They're durable modeling and promoting well all over the world. Under no circumstances disappearing key functions in a brief time, it's a should for you personally of fantastic quality. Guided by the principle of Prudence, Efficiency, Union and Innovation. the business make an awesome efforts to expand its international trade, raise its enterprise. rofit and improve its export scale. We are confident that we'll have a vibrant prospect and to be distributed all over the world in the years to come.
  • The customer service staff's attitude is very sincere and the reply is timely and very detailed, this is very helpful for our deal,thank you.
    5 Stars By Salome from South Africa - 2018.06.21 17:11
    Reasonable price, good attitude of consultation, finally we achieve a win-win situation,a happy cooperation!
    5 Stars By EliecerJimenez from Croatia - 2017.02.18 15:54
    Write your message here and send it to us